Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Pain and its treatment in outpatients with metastatic cancer.
|
N Engl J Med
|
1994
|
9.54
|
2
|
Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study.
|
Ann Intern Med
|
1997
|
3.48
|
3
|
Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group.
|
Ann Intern Med
|
1993
|
3.25
|
4
|
Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators.
|
J Clin Oncol
|
1994
|
1.79
|
5
|
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.
|
Cancer
|
1997
|
1.60
|
6
|
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189.
|
J Clin Oncol
|
2000
|
1.42
|
7
|
A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer. A preliminary report.
|
Cancer
|
1985
|
1.16
|
8
|
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
|
J Clin Oncol
|
1998
|
1.01
|
9
|
Continuous intravenous infusion of 5-fluorouracil in the treatment of refractory breast cancer.
|
Am J Clin Oncol
|
1989
|
0.83
|
10
|
Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids.
|
Cancer
|
1986
|
0.79
|
11
|
Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha.
|
J Immunother
|
1999
|
0.78
|
12
|
21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literature.
|
Am J Clin Oncol
|
2000
|
0.78
|
13
|
Phase II trial of 6-thioguanine in metastatic breast cancer.
|
Cancer Treat Rep
|
1980
|
0.76
|
14
|
Phase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185).
|
Breast Cancer Res Treat
|
1999
|
0.76
|
15
|
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
|
Am J Clin Oncol
|
2000
|
0.76
|
16
|
Hyperaldosteronism associated with liver metastases.
|
JAMA
|
1980
|
0.75
|
17
|
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
|
Cancer Treat Rep
|
1986
|
0.75
|
18
|
Cure of mediastinal seminoma.
|
Ann Intern Med
|
1982
|
0.75
|
19
|
A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma.
|
Am J Clin Oncol
|
1989
|
0.75
|
20
|
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
|
Am J Clin Oncol
|
1995
|
0.75
|
21
|
Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study.
|
Invest New Drugs
|
1990
|
0.75
|
22
|
Burkitt cell leukemia following therapy for Hodgkin disease.
|
Am J Hematol
|
1982
|
0.75
|
23
|
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
|
Cancer Treat Rep
|
1984
|
0.75
|
24
|
Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancer.
|
Cancer
|
1986
|
0.75
|
25
|
Phase II study of goserelin for patients with postmenopausal metastatic breast cancer.
|
J Clin Oncol
|
1993
|
0.75
|
26
|
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot study.
|
Am J Clin Oncol
|
1985
|
0.75
|
27
|
Chemoprevention of 7,12-dimethylbenz(alpha)anthracene (DMBA) induced rat mammary tumors by 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP).
|
J Biol Response Mod
|
1986
|
0.75
|
28
|
Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181).
|
Am J Clin Oncol
|
1998
|
0.75
|
29
|
Combination chemotherapy for advanced colorectal cancer. A pilot study.
|
Am J Clin Oncol
|
1986
|
0.75
|